First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.
Eric Van CutsemI DanielewiczM P SaundersP PfeifferG ArgilésC BorgRobert Glynne-JonesC J A PuntA J Van de WouwM FedyaninD StroyakovskiyH KroeningP Garcia-AlfonsoHarpreet S WasanA FalconeR FougerayA EgorovN AmellalV MoiseyenkoPublished in: British journal of cancer (2022)
NCT02743221 (clinicaltrials.gov).